The forecasted data on antiarrhythmic medicine use in Austria reveals a gradual decline from 2.0 units in 2024 to 1.7 units by 2028. Standing at 2.1 units in 2023, there's a 4.8% year-on-year decrease projected for 2024. The year-on-year variations from 2024 to 2028 depict modest declines, with a Compound Annual Growth Rate (CAGR) of -3.1% over the forecast period, indicating a steady reduction in daily dosages per thousand persons.
Future trends to watch for include advancements in alternative treatments, demographic shifts influencing the prevalence of arrhythmias, and potential changes in healthcare policies that could impact medicine usage rates.
